New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
10:00 EDTARRYArray BioPharma now sees FY13 EPS (55c), prior view (60c)
Consensus for FY13 EPS (58c). Lowered FY13 revenue view to $60M from $62M prior guidance, consensus $63.03M. Guidance from slides for Q2 earnings conference call.
News For ARRY From The Last 14 Days
Check below for free stories on ARRY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 12, 2014
13:48 EDTARRYArray names Sandor Chief Medical Officer to replace Needle
Subscribe for More Information
September 11, 2014
18:15 EDTARRYArray BioPharma names Victor Sandor as Chief Medical Officer
Array BioPharma (ARRY) announced the appointment of Victor Sandor, M.D., as Chief Medical Officer. Prior to joining Array, Sandor was senior VP for Global Clinical Development at Incyte Corporation (INCY). Sandor will replace Array's prior Chief Medical Officer, Michael Needle, M.D., who is leaving the company to pursue other opportunities.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use